Form 4: ANI Pharma Director Sells, Gifts Shares

ANI Pharmaceuticals Director Patrick D. Walsh reported the sale of 8,643 common shares and a gift of 3,000 shares to a charitable fund on November 13, 2025.

Summary

• Patrick D. Walsh, a Director of ANI Pharmaceuticals Inc. (ANIP), reported transactions involving the company's common stock.
• On November 13, 2025, Walsh sold 8,643 shares of common stock at a weighted average price of $86.88 per share. The sales occurred in multiple trades ranging from $86.15 to $87.80.
• On the same date, Walsh made a bona fide gift of 3,000 shares of common stock to a donor-advised fund for charitable purposes, with a reported price of $0.
• Following these transactions, Walsh beneficially owns 58,405 shares of ANI Pharmaceuticals common stock directly.
• The transactions were made pursuant to a Rule 10b5-1 plan.

Sentiment

Score: 5

Explanation: The filing is a routine insider transaction report (Form 4) detailing a sale and a charitable gift of shares. It does not contain information that would significantly alter the company's fundamental outlook or market sentiment, hence a neutral score.

Positives

• The gift of 3,000 shares to a donor-advised fund for charitable purposes demonstrates philanthropic activity by a company director.
• The sale was conducted under a Rule 10b5-1 plan, indicating pre-planned transactions rather than reactive selling.

Negatives

• The sale of 8,643 shares by a director reduces insider ownership, which can sometimes be perceived as a slight negative by investors.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This insider transaction report is a routine disclosure and does not provide information to assess broader industry trends or competitive positioning. It reflects an individual director's personal financial planning.

Comparison to Industry Standards

• This filing reports a standard insider transaction (Form 4) and does not contain information that allows for a comparison of company performance or results against global benchmarks or specific comparable companies/projects.

Related Party Transactions

• A bona fide gift of 3,000 shares of common stock was made to a donor-advised fund for charitable purposes. The reporting person retains no beneficial ownership or control over the donated securities.

Stakeholder Impact

• Shareholders: The sale of a relatively small number of shares by a director is unlikely to have a significant direct impact on the company's share price or long-term shareholder value. The charitable gift has no direct financial impact on other stakeholders.

Key Dates

Keywords

ANI Pharmaceuticals, ANIP, Form 4, Insider Trading, Stock Sale, Charitable Gift, Director Transaction, Patrick D. Walsh, Rule 10b5-1